Graeter T, Bao HH, Shi R, Liu WY, Li WX, Jiang Y, Schmidberger J, Brumpt E, Delabrousse E, Kratzer W, the XUUB Consortium. Evaluation of intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis. World J Gastroenterol 2020; 26(29): 4302-4315 [PMID: 32848335 DOI: 10.3748/wjg.v26.i29.4302]
Corresponding Author of This Article
Wolfgang Kratzer, MD, Professor, Department of Internal Medicine I, University Hospital Ulm, Albert-Einstein-Allee 23, Ulm 89081, Germany. wolfgang.kratzer@uniklinik-ulm.de
Research Domain of This Article
Medicine, General & Internal
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Aug 7, 2020; 26(29): 4302-4315 Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4302
Table 1 Overview of the echinococcosis multilocularis Ulm classification for computed tomography
Primary morphology (Subcriteria)
Pattern of calcification
Type I, Diffuse infiltrating (with cystoid portion / without cystoid portion)
Without calcifications
Type II, Primarily circumscribed tumor-like (with cystoid portion / without cystoid portion)
With feathery calcifications
Type III, Primarily cystoid - intermediate (IIIa), widespread (IIIb) - (with more solid portions at the edge / without more solid portions at the edge)
With focal calcifications
With diffuse calcifications
Type IV, Small-cystoid/metastasis-like
With calcifications primarily at the edge
Type V, Mainly calcified
With a central calcification
Table 2 Patient characteristics
XUUB overall (n = 200)
Xining (n = 50)
Urumqi (n = 50)
Ulm (n = 50)
Besançon (n = 50)
Sex, n (%)
Male
90 (45.0)
22 (44.0)
23 (46.0)
21 (42.0)
24 (48.0)
Female
110 (55.0)
28 (56.0)
27 (54.0)
29 (58.0)
26 (52.0)
Age, yr, n (%)
< 18
8 (4.0)
6 (12.0)
2 (4.0)
0 (0.0)
0 (0.0)
18–40
59 (29.5)
20 (40.0)
26 (52.0)
8 (16.0)
5 (10.0)
41–60
66 (33.0)
24 (48.0)
18 (36.0)
12 (24.0)
12 (24.0)
61–80
50 (25.0)
0 (0.0)
4 (8.0)
26 (52.0)
20 (40.0)
> 81
17 (8.5)
0 (0.0)
0 (0.0)
4 (8.0)
13 (26.0)
Lesion size (mm)
95.6 ± 51.8
108.0 ± 53.0
132.7 ± 46.0
71.4 ± 46.39
70.4 ± 32.3
(11–261)
(21–261)
(36–253)
(11–202)
(13–173)
Number of lesions
3.2 ± 4.5
3.3 ± 5.3
1.8 ± 1.2
5.0 ± 6.5
2.7 ± 2.4
(1–29)
(1–27)
(1–6)
(1–29)
(1–12)
Age (yr)
50.1 ± 20.5
35.5 ± 12.6
38.0 ± 13.9
61.3 ± 16.8
65.7 ± 18.3
(11–91)
(11–55)
(16–77)
(18–85)
(18–91)
Table 3 Primary morphological types classified according to the echinococcosis multilocularis Ulm classification for computed tomography, n (%)
XUUB total (n = 200)
Xining (n = 50)
Urumqi (n = 50)
Ulm (n = 50)
Besançon (n = 50)
Type I
85 (42.5)
18 (36.0)
17 (34.0)
22 (44.0)
28 (56.0)
With cystoid portion
55 (64.7)
13 (72.2)
13 (76.5)
11 (50.0)
18 (64.3)
Without cystoid portion
30 (35.3)
5 (27.8)
4 (23.5)
11 (50.0)
10 (35.7)
Type II
67 (33.5)
17 (34.0)
26 (52.0)
12 (24.0)
12 (24.0)
With cystoid portion
55 (82.09)
13 (76.5)
22 (84.6)
10 (83.3)
10 (83.3)
Without cystoid portion
12 (17.9)
4 (23.5)
4 (15.4)
2 (16.7)
2 (16.7)
Type III
27 (13.5)
13 (26.0)
7 (14.0)
4 (8.0)
3 (6.0)
With more solid portions at the edge
23 (85.19)
11 (84.6)
6 (85.7)
4 (100.0)
2 (66.7)
Without more solid portions at the edge
4 (14.8)
2 (15.4)
1 (14.3)
0 (0.0)
1 (33.3)
Type iiia
8 (4.0)
2 (4.0)
1 (2.0)
2 (4.0)
3 (6.0)
With more solid portions at the edge
7 (87.5)
0 (0.0)
0 (0.0)
0 (0.0)
2 (66.7)
Without more solid portions at the edge
1 (12.5)
2 (100.0)
1 (100.0)
2 (100.0)
1 (33.3)
Type iiib
19 (9.5)
11 (22.0)
6 (12.0)
2 (4.0)
0 (0.0)
With more solid portions at the edge
16 (84.21)
9 (81.8)
5 (83.3)
0 (0.0)
0 (0.0)
Without more solid portions at the edge
3 (15.8)
2 (18.2)
1 (16.7)
2 (100.0)
0 (0.0)
Type IV
17 (8.5)
2 (4.0)
0 (0.0)
9 (18.0)
6 (12.0)
Type V
4 (2.0)
0 (0.0)
0 (0.0)
3 (6.0)
1 (2.0)
Table 4 Patients with extrahepatic disease manifestation from alveolar echinococcosis
Patient
Center
Age
Sex
Involved organs
No. 1
Besançon
91
Female
Spleen
No. 2
Besançon
86
Male
Cranial calotte
No. 3
Besançon
89
Female
Lung
No. 4
Urumqi
56
Male
Lung
No. 5
Urumqi
49
Male
Lung
No. 6
Urumqi
53
Male
Retroperitoneal (distant from the liver)
No. 7
Urumqi
37
Female
Retroperitoneal (distant from the liver)
No. 8
Urumqi
30
Male
Lung
No. 9
Urumqi
45
Female
Lung
No. 10
Xining
32
Female
Lung
No. 11
Xining
51
Female
Lung
No. 12
Xining
30
Female
Brain, lung
No. 13
Xining
17
Male
Lung
No. 14
Xining
29
Male
Brain, lung
No. 15
Xining
50
Male
Brain, lung
No. 16
Xining
49
Male
Lung
Citation: Graeter T, Bao HH, Shi R, Liu WY, Li WX, Jiang Y, Schmidberger J, Brumpt E, Delabrousse E, Kratzer W, the XUUB Consortium. Evaluation of intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis. World J Gastroenterol 2020; 26(29): 4302-4315